This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Twister Biotech, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Christopher Elbert Coker: Innovator in Gene Therapy
Introduction
Christopher Elbert Coker is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of gene therapy, particularly in the development of innovative compositions that have the potential to treat various diseases.
Latest Patents
Coker holds a patent for "P53, P63, and P73 homo-tetrameric compositions." This invention involves the creation of fusion proteins that maintain the activity of the original proteins while preventing them from hetero-tetramerizing or dimerizing. The compositions utilize non-human tetramerization sequences, which minimizes the risk of interaction with other tetramerization domains within human cells. This advancement opens new avenues for gene therapy treatments targeting diseases such as cancer, autoimmune disorders, and autoinflammatory diseases.
Career Highlights
Coker is currently associated with Twister Biotech, Inc., where he continues to push the boundaries of gene therapy research. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.
Collaborations
Coker collaborates with Daniel James Catanese, Jr., contributing to the advancement of their shared goals in the field of biotechnology.
Conclusion
Christopher Elbert Coker's innovative work in gene therapy exemplifies the potential of scientific research to transform medical treatments. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile